Li‐Tain Yeh
Impact in
- Hepatology top 2%
- Hepatitis C virus research
- Nephrology top 2%
- Gout, Hyperuricemia, Uric Acid
Papers in
-
- HIV/AIDS drug development and treatment 19
- Hepatology 19
- Hepatitis C virus research 19
- Co-authors
- Chin‐Chung Lin (20 shared papers)Barry Quart (8 shared papers)Zancong Shen (12 shared papers)Jeffrey N. Miner (6 shared papers)Christine Xu (9 shared papers)Kimberly J. Manhard (7 shared papers)Zhi Hong (5 shared papers)Cory Iverson (7 shared papers)
- Journals
- Antimicrobial Agents and Chemotherapy (8 papers)Annals of the Rheumatic Diseases (5 papers)Journal of Chromatography B (4 papers)The Journal of Clinical Pharmacology (4 papers)Journal of Clinical Oncology (3 papers)
- Partner nations
- United StatesUnited KingdomTaiwan
In The Last Decade
Li‐Tain Yeh
49 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 82
- Hepatology 268
- Nephrology 242
- Infectious Diseases 318
- Virology 81
- Pharmacology 75
Countries citing papers authored by Li‐Tain Yeh
This map shows the geographic impact of Li‐Tain Yeh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li‐Tain Yeh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li‐Tain Yeh more than expected).
Fields of papers citing papers by Li‐Tain Yeh
This network shows the impact of papers produced by Li‐Tain Yeh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li‐Tain Yeh. The network helps show where Li‐Tain Yeh may publish in the future.
Co-authors
The 25 scholars most cited alongside Li‐Tain Yeh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 156 | |
| 2 | 2016 | 107 | |
| 3 | 2014 | 82 | |
| 4 | 2006 | 53 | |
| 5 | 2003 | 48 | |
| 6 | 2013 | 46 | |
| 7 | 2004 | 44 | |
| 8 | 2015 | 42 | |
| 9 | 2015 | 41 | |
| 10 | 2015 | 36 | |
| 11 | 2010 | 35 | |
| 12 | 2007 | 32 | |
| 13 | 2006 | 30 | |
| 14 | 2003 | 29 | |
| 15 | 2002 | 28 | |
| 16 | 2003 | 27 | |
| 17 | 2007 | 25 | |
| 18 | 2000 | 23 | |
| 19 | 2016 | 23 | |
| 20 | 2004 | 22 |
About Li‐Tain Yeh
Li‐Tain Yeh is a scholar working on Infectious Diseases, Hepatology, Molecular Biology, Oncology and Nephrology, having authored 50 papers that have together received 1.2k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (19 papers), Hepatitis C virus research (19 papers), Gout, Hyperuricemia, Uric Acid (11 papers), Hepatitis B Virus Studies (9 papers), Drug Transport and Resistance Mechanisms (6 papers), Biochemical and Molecular Research (6 papers), Melanoma and MAPK Pathways (5 papers) and Colorectal Cancer Treatments and Studies (4 papers). The work is most often cited by research in Hepatology (268 citations), Nephrology (242 citations), Infectious Diseases (318 citations), Virology (81 citations) and Pharmacology (75 citations). Li‐Tain Yeh has collaborated with scholars based in United States, United Kingdom and Taiwan. Frequent co-authors include Chin‐Chung Lin, Barry Quart, Zancong Shen, Jeffrey N. Miner, Christine Xu, Kimberly J. Manhard, Zhi Hong, Cory Iverson, Robert Hamatake and Jean‐Luc Girardet. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Annals of the Rheumatic Diseases, Journal of Chromatography B, The Journal of Clinical Pharmacology and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.